4//SEC Filing
Ross Andrew L. 4
Accession 0001104659-21-144593
CIK 0001558569other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 8:01 PM ET
Size
19.9 KB
Accession
0001104659-21-144593
Insider Transaction Report
Form 4
iSpecimen Inc.ISPC
Ross Andrew L.
Director10% Owner
Transactions
- Purchase
Common Stock
2021-11-08$5.73/sh+1,000$5,730→ 1,312,024 total(indirect: By LLC) - Purchase
Common Stock
2021-11-15$5.30/sh+500$2,650→ 1,313,524 total - Purchase
Common Stock
2021-06-23$6.52/sh+400$2,608→ 1,311,024 total - Purchase
Common Stock
2021-11-10$5.85/sh+500$2,925→ 1,312,524 total - Purchase
Common Stock
2021-11-15$5.29/sh+500$2,645→ 1,313,024 total - Award
Restricted Stock Units
2021-07-30+2,500→ 2,500 total→ Common Stock (2,500 underlying) - Purchase
Common Stock
2021-06-17$6.27/sh+100$627→ 1,310,624 total - Purchase
Common Stock
2021-11-16$5.19/sh+1,000$5,190→ 1,314,524 total(indirect: By LLC) - Award
Non-Qualified Stock Options
2021-07-30+13,525→ 13,525 total→ Common Stock (13,525 underlying)
Footnotes (4)
- [F1]Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.
- [F3]The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company.
- [F4]Including 1,310,524 shares of common stock acquired by the Reporting Person on June 21, 2021, as reported in the Form 4 filed with the Securities and Exchange Commission on June 23, 2021.
Documents
Issuer
iSpecimen Inc.
CIK 0001558569
Entity typeother
Related Parties
1- filerCIK 0001857013
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 8:01 PM ET
- Size
- 19.9 KB